From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA guidance highlights inappropriate use of power morcellation, but concern about interpretation lingers

from Healio

An FDA warning about the use of laparoscopic power morcellators to treat uterine fibroids has polarized the gynecologic oncology community. The agency’s “immediately in effect” guidance warns against the use of morcellators in hysterectomies or myomectomies in the majority of women due to the potential that they can spread undetected uterine sarcomas. Yet, intense debate rages among surgeons and clinicians about whether FDA intended for power morcellation to be abandoned entirely, or if the agency intentionally left its guidance vague enough to allow surgeons to perform the procedures in patients who provide informed consent. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063